None listed
Conditions
Brief summary
Diabetes has been understudied in the substance use population and there have been strong calls to address this paucity. People with substance use problems are at high risk of developing T2D yet screening and education is not integrated into routine care. The aim of the proposed study is to assess the effectiveness of the T2D risk communication tool on T2D risk perceptions and behavioural intentions among people with alcohol or other drug problems (i.e. participants who are receiving treatment/support for substance use problems). Specifically, the study will examine whether personalised T2D risk feedback is more effective in improving risk perceptions and increasing health behavioural intentions to reduce T2D risk compared to an active control group. We hypothesise that participants receiving the personalised T2D risk feedback will report significantly more accurate T2D risk perceptions and greater behavioural intentions compared to participants in the active control group.
Interventions
Brief Online Type 2 Diabetes Risk Communication Intervention
The randomized controlled trial will replicate the procedures that have been used in a previous online study (linked study record). (1) Participants will be directed to the online survey (i.e. Qualtrics) to complete the study. Upon starting the survey, participants will have to give informed consent in order to proceed. (2) Participants will first undergo the screening phase by completing a series of questions pertaining to their demo
Brief Online Type 2 Diabetes Risk Communication Intervention The randomized controlled trial will replicate the procedures that have been used in a previous online study (linked study record). (1) Participants will be directed to the online survey (i.e. Qualtrics) to complete the study. Upon starting the survey, participants will have to give informed consent in order to proceed. (2) Participants will first undergo the screening phase by completing a series of questions pertaining to their demographics, drug and/or alcohol history and the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK). Questions/questionnaires in the screening phase were compiled specifically for this study and will take approximately 5 minutes to complete. Participants who do not meet the eligibility requirements will be screened out of the survey. (3) Eligible participants will proceed on to the intervention phase and will be randomized to be in either the intervention or active control group. Participants in the intervention group will receive the personalized Type 2 diabetes risk message, while participants in the active control group will receive a COVID-19 health message. (4) Participants will complete a series of questions on risk perception and related-behavioural intentions pre- and post-intervention. (5) At the end of the survey, participants will be given the option to download their personalised Type 2 diabetes risk message and the COVID-19 health message. Participants will also be directed to a second survey to enter their email address to enter the lucky draw (10 x $50 visa gift cards). Type 2 Diabetes Risk Message (Intervention): For this study, we will focus on the personalized/tailored manipulation, which had the most promising results (from the previous study), and compare it with an active control group. The message intervention consists of three sections: (1) T2D risk estimate and feedback, (2) general information on T2D, and (3) recommendations for lifestyle changes. Following the previous study, we have made some changes based on the needs of the AOD population i.e. provided a breakdown of AUSDRISK score so that participants can better comprehend their level of risk, additional graphics and videos to make the information more appealing and easier to understand. The personalized/tailored manipulation is specifically applied in Section 1, which provides participants with their individualized risk estimate. Each section will take approximately 2-3 minutes and overall it is estimated that participants will take no more than 10 minutes to read through the intervention. - Section 1: Participants will receive an individualized tailored risk message which includes the AUSDRISK risk score, risk category, specific risk estimate (e.g. one person in every 50 will develop diabetes) in text and graphic. - Section 2: Participants will receive a general fact sheet on T2D that discusses diabetes and its risk, risk factors and complications. This fact sheet is derived from publicly accessible information from the International Diabetes Federation and Diabetes Australia. - Section 3: The lifestyle recommendation section is constructed using clinical guidelines for T2D prevention (The National Institute of Diabetes and Digestive and Kidney Diseases) that focused on the effects of health behaviour change. It includes general advice on making lifestyle changes to reduce the risk of T2D as well as specific steps to lower the risk (e.g. lose weight, get active, and eat healthy food).
Sponsors
University of Wollongong
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
This study involves a screening phase and intervention phase to maximise data collection. Specifically, this will allow us to understand the rates of diabetes among people with drug and alcohol problems. The inclusion criteria for the screening phase are: - People aged 18 and above living in Australia or the United States of America (USA), - have had problems with illicit drugs or alcohol and/or have attended alcohol or other drugs (AOD) treatment in the past 12 months For participants to proceed on to the intervention phase, the inclusion criteria for participants are: - do not have a diabetes diagnosis, - score an intermediate or high risk on the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK).
Exclusion criteria
None
Outcome results
None listed